Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$4.39 - $6.36 $41,590 - $60,254
-9,474 Reduced 98.58%
136 $1,000
Q1 2024

May 07, 2024

BUY
$5.3 - $7.61 $885 - $1,270
167 Added 1.77%
9,610 $54,000
Q4 2023

Feb 01, 2024

SELL
$4.5 - $7.51 $94 - $157
-21 Reduced 0.22%
9,443 $63,000
Q3 2023

Nov 07, 2023

BUY
$7.85 - $10.68 $1,287 - $1,751
164 Added 1.76%
9,464 $76,000
Q2 2023

Aug 07, 2023

BUY
$9.23 - $11.23 $85,839 - $104,439
9,300 New
9,300 $94,000
Q3 2021

Nov 02, 2021

SELL
$12.2 - $15.93 $732 - $955
-60 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$11.7 - $16.11 $63,647 - $87,638
-5,440 Reduced 98.91%
60 $1,000
Q2 2020

Aug 07, 2020

BUY
$7.75 - $22.61 $42,625 - $124,355
5,500 New
5,500 $71,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $51.7M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.